Keyphrases
Chronic Myeloid Leukemia
100%
Protein Kinase
100%
Bone Marrow Cells
80%
Purging
40%
DNA Synthesis
40%
Accelerated Phase
40%
Malignant Cells
20%
Bone Marrow
20%
Apoptosis
20%
Cell Culture Model
20%
Chronic Phase
20%
Healthy Donors
20%
Oncogene
20%
Leukemia
20%
Relapse Risk
20%
Leukemia Cells
20%
Colony Forming Units
20%
Philadelphia Chromosome
20%
Leukemia Patients
20%
Allogeneic Bone Marrow Transplantation
20%
Toxic Side Effects
20%
Colony Formation Assay
20%
Transformed Fibroblasts
20%
Working Diagnosis
20%
BRAF Inhibitor (BRAFi)
20%
MEK Inhibitor (MEKi)
20%
In Vivo Applications
20%
Leukaemic Cells
20%
RAF Kinase
20%
Medicine and Dentistry
Chronic Myelogenous Leukemia
100%
Antileukemic Agent
100%
Cyclic AMP Dependent Protein Kinase
100%
Bone Marrow Cell
80%
Philadelphia 1 Chromosome
60%
DNA Synthesis
40%
Ex Vivo
20%
Side Effect
20%
Programmed Cell Death
20%
Transplantation
20%
Oncogene
20%
Leukemia Cell
20%
Autologous Bone Marrow Transplantation
20%
MEK Inhibitor
20%
Transformed Cell
20%
Colony Forming Cell
20%
Raf Protein
20%
CFU Counting
20%
Leukemia
20%
Cell Culture
20%
Fibroblast
20%
Pharmacology, Toxicology and Pharmaceutical Science
Cyclic AMP Dependent Protein Kinase
100%
Chronic Myeloid Leukemia
100%
Antileukemic Agent
100%
Philadelphia 1 Chromosome
60%
Leukemia
40%
Cell Culture
20%
Elimination
20%
Side Effect
20%
Mitogen Activated Protein Kinase Kinase Inhibitor
20%
Raf Protein
20%
Biochemistry, Genetics and Molecular Biology
Cyclic Adenosine Monophosphate
100%
Protein Kinase A
100%
Philadelphia Chromosome
37%
DNA Synthesis
25%
Oncogene
12%
Colony Forming Unit S
12%
Cell Culture
12%
Agonist
12%
Colony Forming Cell
12%
MEK Inhibitor
12%
Raf Kinase
12%
Fibroblast
12%
Programmed Cell Death
12%